Description
COVID longue
Lignes directrices canadiennes
Dernière mise à jour du 17 juillet 2025
Nouvelles publications scientifiques
- Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohorton 15 mai 2026
EClinicalMedicine. 2026 Apr 1;94:103846. doi: 10.1016/j.eclinm.2026.103846. eCollection 2026 Apr.ABSTRACTBACKGROUND: Long COVID has emerged as a global health challenge, with increasing evidence of […]
- Evaluating a Digital Patient Reported Outcome Measure for Long COVID in a Community Rehabilitation Serviceon 15 mai 2026
J Prim Care Community Health. 2026 Jan-Dec;17:21501319261437896. doi: 10.1177/21501319261437896. Epub 2026 May 4.ABSTRACTBACKGROUND: Long COVID presents with a wide range of persistent symptoms which […]
- The neuropsychiatric features of Long COVID in older adults and the potential association with neuroinflammation: Preliminary observations in a small cohorton 15 mai 2026
J Neurol Sci. 2026 Apr 11;486:125915. doi: 10.1016/j.jns.2026.125915. Online ahead of print.ABSTRACTBACKGROUND: The underlying mechanism of neuropsychiatric features of Long COVID remains unclear; […]
- Outcomes of Patients with Neurocognitive Symptoms Attending a Long COVID Clinic: A Longitudinal Cohort Studyon 15 mai 2026
Committee on Examining the Working Definition for Long COVID, Board on Health Sciences Policy, Board on Global Health, Health and Medicine Division, National Academies of Sciences, Engineering, and […]
- Addressing the Costs and Care for Long COVIDon 10 avril 2026
OECD Featured topics Agriculture and fisheries Climate change Development Digital Economy Education and skills Employment Environment Finance and investment Governance Health Industry, […]
- Engaging patients and researchers in RECOVER clinical trial protocol development: Key lessonson 10 avril 2026
J Clin Transl Sci. 2026 Feb 18;10(1):e49. doi: 10.1017/cts.2026.10702. eCollection 2026.ABSTRACTThe RECOVER Clinical Trials Protocol Working Groups (PWGs) were established to rapidly design trials […]
- Physiotherapy management of long COVID in adultson 10 avril 2026
J Physiother. 2026 Apr 2:S1836-9553(26)00016-0. doi: 10.1016/j.jphys.2026.03.001. Online ahead of print.NO ABSTRACTPMID:41933948 | DOI:10.1016/j.jphys.2026.03.001
- The case for routine patient review in long COVID researchon 10 avril 2026
Lancet Infect Dis. 2026 Mar 31:S1473-3099(26)00134-9. doi: 10.1016/S1473-3099(26)00134-9. Online ahead of print.NO ABSTRACTPMID:41932346 | DOI:10.1016/S1473-3099(26)00134-9
- Postacute Sequelae Following Omicron COVID-19 in Patients With Canceron 10 avril 2026
JAMA Netw Open. 2026 Mar 2;9(3):e264037. doi: 10.1001/jamanetworkopen.2026.4037.ABSTRACTIMPORTANCE: Information on the burden of postacute sequelae of SARS-CoV-2 infection (or long COVID) in patients […]
- Exploring duplication in reviews of Long COVID: 2020-2023on 10 avril 2026
Syst Rev. 2026 Apr 1. doi: 10.1186/s13643-026-03174-1. Online ahead of print.ABSTRACTBACKGROUND: The unnecessary duplication of reviews is a recognised problem in the field of evidence synthesis. […]
- Between silence and solutions: a global guideline review of long COVID care and services in Australiaon 10 avril 2026
BMC Health Serv Res. 2026 Mar 20. doi: 10.1186/s12913-026-14268-w. Online ahead of print.NO ABSTRACTPMID:41862917 | DOI:10.1186/s12913-026-14268-w
- Understanding the role of psychological factors in long COVID: a network analysis approachon 10 avril 2026
Eur J Public Health. 2026 Mar 14;36(2):ckag038. doi: 10.1093/eurpub/ckag038.ABSTRACTLong COVID (LC) is a heterogeneous, multisystem condition that persists beyond the acute phase of SARS-CoV-2 […]
- Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Studyon 10 avril 2026
Health Expect. 2026 Apr;29(2):e70591. doi: 10.1111/hex.70591.ABSTRACTBACKGROUND: At the start of the coronavirus disease-2019 (COVID-19) pandemic in early 2020, the long-term outcomes for survivors […]
- Long COVID Prevalence Decreases as Recovery Rates Improveon 10 avril 2026
JAMA. 2026 Mar 20. doi: 10.1001/jama.2026.1021. Online ahead of print.NO ABSTRACTPMID:41860534 | DOI:10.1001/jama.2026.1021
- Association of long COVID with health-related quality-of-life outcomeson 10 avril 2026
Sci Rep. 2026 Mar 19. doi: 10.1038/s41598-026-36189-8. Online ahead of print.ABSTRACTThe association of long COVID with health-related quality-of-life (HrQOL) has not been well-characterized. […]
- Clinical practice guideline for long COVID prevention and treatmenton 10 avril 2026
Eur Respir J. 2026 Mar 19:2502611. doi: 10.1183/13993003.02611-2025. Online ahead of print.ABSTRACTBACKGROUND: This guideline aims to address key clinical questions of long COVID, and to provide […]
- Long-term trends in Post-COVID severity: a machine learning analysis from the POP/COVIDOM cohort of the German NAPKON Cohort Networkon 10 avril 2026
EClinicalMedicine. 2026 Mar 10;93:103822. doi: 10.1016/j.eclinm.2026.103822. eCollection 2026 Mar.ABSTRACTBACKGROUND: Post-COVID syndrome (PCS) affects many survivors with varying symptom profiles […]
- Treatment of post-COVID symptoms with auricular vagus nerve stimulationon 10 avril 2026
Wien Med Wochenschr. 2026 Mar 18. doi: 10.1007/s10354-026-01141-y. Online ahead of print.ABSTRACTWe present a retrospective analysis of nine long COVID patients undergoing auricular vagus nerve […]
- Outcomes of Patients with Neurocognitive Symptoms Attending a Long COVID Clinic: A Longitudinal Cohort Studyon 10 avril 2026
J Gen Intern Med. 2026 Mar 19. doi: 10.1007/s11606-026-10307-8. Online ahead of print.ABSTRACTBACKGROUND: Data are lacking on longitudinal outcomes of patients treated in primary care-led long COVID […]
- Cognition and Long COVID: a Reviewon 16 mars 2026
Curr Neurol Neurosci Rep. 2026 Mar 13;26(1):15. doi: 10.1007/s11910-026-01485-3.NO ABSTRACTPMID:41824149 | DOI:10.1007/s11910-026-01485-3
Maladie de Lyme
- Lyme disease as a rare trigger for autoimmune hemolytic anemiaon 15 mai 2026
Lyme disease, caused by Borrelia burgdorferi, is a zoonotic infection affecting the skin, nervous system, joints, and heart. Diagnosis relies on clinical history, symptoms, and a two steps serologic […]
- Sex and menopause-based differences in presentation of early Lyme disease: A prospective cohort studyon 15 mai 2026
Although prior research has established sex and menopausal status-based differences in immune response, susceptibility, and severity to a variety of pathogens, their relevance in early Lyme disease […]
- Spatial modeling of Borrelia genospecies in human-biting ticks from the French citizen science programme CiTIQUEon 15 mai 2026
Sci Rep. 2026 Apr 21;16(1):12919. doi: 10.1038/s41598-026-42619-4.ABSTRACTIn Europe, Lyme borreliosis is the most common vector-borne human disease, mainly caused by Borrelia afzelii and Borrelia […]
- Lyme Neuroborreliosis With Acute Encephalopathy Despite Early Antibiotic Therapy: A Case Reporton 10 avril 2026
Am J Case Rep. 2026 Apr 6;27:e951927. doi: 10.12659/AJCR.951927.ABSTRACTBACKGROUND Lyme disease is a tick-borne infection caused by spirochetes of the Borrelia burgdorferi sensu lato species complex […]
- Lyme borreliosison 10 avril 2026
Nat Rev Dis Primers. 2026 Mar 26;12(1):15. doi: 10.1038/s41572-026-00691-0.ABSTRACTLyme borreliosis is the most common tick-borne disease in the northern hemisphere. It is a zoonosis caused by […]
- Evaluation of immunoreactive epitopes in the sera and cerebrospinal fluid of patients with post-treatment Lyme disease syndromeon 16 mars 2026
Sci Rep. 2026 Mar 13. doi: 10.1038/s41598-026-42941-x. Online ahead of print.NO ABSTRACTPMID:41826406 | DOI:10.1038/s41598-026-42941-x
- Pilot study of psilocybin in patients with post-treatment lyme diseaseon 16 mars 2026
Sci Rep. 2026 Feb 25;16(1):7497. doi: 10.1038/s41598-026-38091-9.ABSTRACTLyme disease, caused by the bacterium Borrelia burgdorferi, is the most common vector-borne disease in the United States and […]
- EXPRESS: A Comprehensive Review of Lyme disease in Latin Americaon 16 mars 2026
J Investig Med. 2026 Feb 25:10815589261429530. doi: 10.1177/10815589261429530. Online ahead of print.ABSTRACTLyme disease (LD) is caused by a bacterial genospecies complex named Borrelia burgdorferi […]
- Lyme Disease and Health Care Costson 6 février 2026
JAMA Netw Open. 2026 Jan 2;9(1):e2552518. doi: 10.1001/jamanetworkopen.2025.52518.ABSTRACTIMPORTANCE: Lyme disease (LD) is the most common vector-borne illness in the US. Given the increasing […]
- Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Swedenon 6 février 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
- A human Lyme disease vaccine: two steps forward on the path to preventionon 6 février 2026
Expert Rev Vaccines. 2026 Dec;25(1):2607482. doi: 10.1080/14760584.2025.2607482. Epub 2025 Dec 25.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
- Deficiencies in communication between clinical microbiological laboratories and physicians may impair the diagnosis of Lyme borreliosis: A study of the use and application of serology in three neighbouring counties in Swedenon 9 janvier 2026
PLoS One. 2025 Dec 26;20(12):e0339449. doi: 10.1371/journal.pone.0339449. eCollection 2025.ABSTRACTPURPOSE: The diagnosis of Lyme borreliosis (LB) can be challenging. The aim of this study was to […]
- Early brain changes in Lyme disease are associated with clinical outcomeson 9 janvier 2026
Brain Behav Immun Health. 2025 Dec 2;50:101153. doi: 10.1016/j.bbih.2025.101153. eCollection 2025 Dec.ABSTRACTIn Lyme disease (LD), 10-20 % of patients develop persistent symptoms following […]
- A human Lyme disease vaccine: two steps forward on the path to preventionon 9 janvier 2026
Expert Rev Vaccines. 2025 Dec 21:2607482. doi: 10.1080/14760584.2025.2607482. Online ahead of print.ABSTRACTINTRODUCTION: Lyme disease is caused by the tick-borne spirochete pathogen Borrelia […]
- Guidelines for Lyme borreliosis: treatmenton 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105204. doi: 10.1016/j.idnow.2025.105204. Epub 2025 Nov 26.ABSTRACTThe aim of the clinical practice guideline is to support healthcare professionals in the diagnosis […]
- Guidelines for Lyme borreliosis: clinical manifestationson 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105202. doi: 10.1016/j.idnow.2025.105202. Epub 2025 Nov 28.ABSTRACTLyme borreliosis (LB) is a tick-borne zoonosis caused by spirochetes belonging to the Borrelia […]
- Guidelines for Lyme borreliosis: Diagnostic strategieson 9 janvier 2026
Infect Dis Now. 2025 Dec;55(8S):105203. doi: 10.1016/j.idnow.2025.105203. Epub 2025 Nov 26.ABSTRACTThe diagnosis of Lyme borreliosis (LB) relies primarily on clinical evaluation supported by […]
- Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Caseson 5 Décembre 2025
J Health Econ Outcomes Res. 2025 Nov 20;12(2):221-228. doi: 10.36469/001c.146618. eCollection 2025.ABSTRACTBackground: Lyme disease, the most common vector-borne disease in Minnesota, is estimated to […]
- Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme diseaseon 5 Décembre 2025
NPJ Vaccines. 2025 Dec 4. doi: 10.1038/s41541-025-01326-3. Online ahead of print.ABSTRACTThere is currently no Lyme disease (LD) vaccine available for use in humans. Outer surface protein C (OspC) of […]
- Genetic landscape of Borrelia burgdorferi sensu stricto in Canada: a study of genetic diversityon 5 Décembre 2025
Sci Rep. 2025 Nov 20;15(1):40954. doi: 10.1038/s41598-025-24758-2.ABSTRACTBorrelia burgdorferi sensu stricto (s.s.), the causative agent of Lyme disease in North America, exhibits considerable […]
Encéphalomyélite myalgique
- Underuse of Pharmacologic Therapies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Before Specialist Evaluationon 15 mai 2026
Ann Fam Med. 2026 Apr 29:250266. doi: 10.1370/afm.250266. Online ahead of print.ABSTRACTPURPOSE: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem neurologic disease […]
- The efficacy of exercise in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysison 15 mai 2026
J Psychosom Res. 2026 Apr 15;207:112677. doi: 10.1016/j.jpsychores.2026.112677. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the efficacy of exercise training for patients with myalgic […]
- Comparing ME/CFS following mononucleosis with Long COVIDon 15 mai 2026
Chronic Illn. 2026 Apr 15:17423953251347108. doi: 10.1177/17423953251347108. Online ahead of print.ABSTRACTObjectivesLong COVID following SARS-CoV-2 and Myalgic Encephalomyelitis/Chronic Fatigue […]
- Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3(rd) International Conference of the Charite Fatigue Centeron 10 avril 2026
Autoimmun Rev. 2026 Mar 25:104043. doi: 10.1016/j.autrev.2026.104043. Online ahead of print.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystemic disorder […]
- Likely neurodivergence and variant connective tissue in patients with chronic pain/chronic fatigue: a case-control studyon 10 avril 2026
J Psychiatr Res. 2026 Jun;197:125-132. doi: 10.1016/j.jpsychires.2026.02.036. Epub 2026 Feb 18.ABSTRACTNeurodivergent traits are frequently observed in individuals with chronic pain and/or chronic […]
- Exercise interventions for physical function, psychological health, and quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia: A systematic review and network meta-analysison 10 avril 2026
J Psychosom Res. 2026 Mar 5;206:112618. doi: 10.1016/j.jpsychores.2026.112618. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia […]
- Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorderson 10 avril 2026
Immunotargets Ther. 2026 Feb 2;15:581262. doi: 10.2147/ITT.S581262. eCollection 2026.ABSTRACTPostural orthostatic tachycardia syndrome (POTS), myalgic encephalomyelitis/chronic fatigue syndrome […]
- ACHTSAM study protocol: outreach diagnostics and assessment of tolerability in severe ME/CFS-a pilot studyon 10 avril 2026
Author Names: Fricke C.,Deibert P.,Maier P.,Kern W.,Krumnau O.,Barsch F. Database Source: Embase Daily Updates Journal Title: BMJ open […]
- Evidence of White Matter Neuroinflammation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Diffusion-Based Neuroinflammation Imaging Studyon 16 mars 2026
Hum Brain Mapp. 2026 Mar;47(4):e70505. doi: 10.1002/hbm.70505.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disorder with suspected neuroinflammatory […]
- Effect of Prolong Life With Nine Turn Method on chronic fatigue syndrome clinical symptoms and roles of gut microbiota: a exploratory randomized controlled trialon 16 mars 2026
Complement Ther Med. 2026 Mar 8:103353. doi: 10.1016/j.ctim.2026.103353. Online ahead of print.ABSTRACTBACKGROUND: Traditional Chinese Qigong exercises (Prolong Life With Nine Turn Method) are […]
- Chronic fatigue syndrome: From etiology and mechanism to diagnosis and treatmenton 16 mars 2026
J Psychiatr Res. 2026 Feb 13;196:171-184. doi: 10.1016/j.jpsychires.2026.02.026. Online ahead of print.ABSTRACTMyalgic encephalomyelitis (ME), commonly known as chronic fatigue syndrome (CFS), is a […]
- ACHTSAM study protocol: outreach diagnostics and assessment of tolerability in severe ME/CFS-a pilot studyon 16 mars 2026
BMJ Open. 2026 Mar 6;16(3):e113095. doi: 10.1136/bmjopen-2025-113095.ABSTRACTINTRODUCTION: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, multisystem condition that often […]
- Indistinguishable mitochondrial phenotypes after exposure of healthy myoblasts to myalgic encephalomyelitis/chronic fatigue syndrome or control serumon 6 février 2026
PLoS One. 2026 Feb 3;21(2):e0341334. doi: 10.1371/journal.pone.0341334. eCollection 2026.ABSTRACTMyalgic Encephalomyelitis (ME) / Chronic Fatigue Syndrome is a disease of uncertain aetiology that […]
- Chronic Fatigue Syndrome Induced by Environmental Toxic Exposure: Effects of Polyhexamethyleneguanidine Phosphate Exposure on Mitochondrial Function and Neural Healthon 6 février 2026
Environ Res. 2026 Jan 27:123874. doi: 10.1016/j.envres.2026.123874. Online ahead of print.ABSTRACTLarge-scale human casualties have been reported following exposure to humidifier disinfectants (HDs), […]
- Associations between heart rate and physical activity in people with post-COVID-19 condition accounting for myalgic encephalomyelitis/chronic fatigue syndrome symptomson 6 février 2026
J Rehabil Med. 2026 Jan 27;58:jrm43340. doi: 10.2340/jrm.v58.43340.ABSTRACTBACKGROUND: Tachycardia after mild activity or during rest is a common complaint among people with post-COVID-19 condition […]
- Tuina therapy for patients with chronic fatigue syndrome: a randomized controlled trialon 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07624-7. Online ahead of print.ABSTRACTBACKGROUND: Chronic fatigue syndrome (CFS) is a complex and disabling disorder characterized by persistent […]
- Multi-omics identifies lipid accumulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cell lines: a case-control studyon 9 janvier 2026
J Transl Med. 2026 Jan 8. doi: 10.1186/s12967-025-07620-x. Online ahead of print.ABSTRACTBACKGROUND: In recent years, evidence has indicated a metabolic shift towards increased demand for lipids in […]
- Evaluating working memory functioning in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysison 9 janvier 2026
Psychol Health Med. 2026 Jan 8:1-30. doi: 10.1080/13548506.2025.2606183. Online ahead of print.ABSTRACTIndividuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) frequently report […]
- Wheat and chaff in Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) in clinics and laboratoryon 9 janvier 2026
J Transl Med. 2026 Jan 5;24(1):20. doi: 10.1186/s12967-025-07397-z.NO ABSTRACTPMID:41491817 | DOI:10.1186/s12967-025-07397-z
- Theoretical foundation of the Activity Calculator - a method for fatigue managementon 9 janvier 2026
Scand J Occup Ther. 2025 Jan;32(1):2608471. doi: 10.1080/11038128.2025.2608471. Epub 2025 Dec 31.ABSTRACTBACKGROUND: Chronic fatigue impacts individuals' ability to engage in daily activities and […]
CCAI
- Persistent physical symptoms not explained by structural abnormalities or disease processes: a primary care approach to promote recovery - PubMedon 10 avril 2026
Background: A substantial proportion of people consulting primary care practitioners have symptoms that persist even after structural problems and diseases have been excluded. They experience […]
- Seeing the forest through the trees: Harmonizing infection-associated chronic illnesses researchon 16 mars 2026
Proc Natl Acad Sci U S A. 2026 Feb 24;123(8):e2600628123. doi: 10.1073/pnas.2600628123. Epub 2026 Feb 18.NO ABSTRACTPMID:41706889 | DOI:10.1073/pnas.2600628123
- Progress Toward Understanding Infection-Associated Chronic Conditions and Illnesses - PubMedon 6 février 2026
Display options Format AbstractPubMedPMID No abstract available Keywords: COVID-19; IACCI; Infection-associated chronic conditions and infections; Long COVID; bacteria; chronic fatigue syndrome; […]
- Long COVID as an Infection-Associated Chronic Condition: Implicationson 6 février 2026
Am J Health Promot. 2025 Jul;39(6):960-965. doi: 10.1177/08901171241308066b. Epub 2025 Jun 8.ABSTRACTA link between infection and chronic illness has been recognized, along with the complexities of […]
Études cliniques
- Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinicon 15 mai 2026
Conditions: Covid19; Long COVID Interventions: Other: Medical follow-up Sponsors: Emilia Falcone, MD Recruiting
- Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)on 15 mai 2026
Conditions: Diabetes Mellitus; COVID-19; Post-Acute COVID-19 Syndrome Interventions: Other: No intervention (observational study) Sponsors: Algerian Society of Diabetology; Novo Nordisk A/S; […]
- Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythmson 15 mai 2026
Conditions: Post-COVID-19 Syndrome Sponsors: Hacettepe University Recruiting
- Effect of a Non-pharmacological Intervention on Endothelial Function, Body Composition, and Physical Functionality in Recovered COVID-19 Patients.on 15 mai 2026
Conditions: Supplemental Nutrition Assistance Program Education; Post COVID Syndrome; Endothelial Function Interventions: Dietary Supplement: L-citrulline supplementation Sponsors: Instituto […]
- COVID-19 Outcome Prediction Algorithmon 15 mai 2026
Conditions: COVID-19; Post Acute Sequelae of COVID-19; Long COVID; Organ Dysfunction Syndrome, Multiple; Frailty Syndrome Interventions: Other: Blood and nasal swab sampling Sponsors: University of […]
- Tele-exercise Training Program for Long COVIDon 15 mai 2026
Conditions: Long COVID Interventions: Device: Telehealth exercise training program; Behavioral: Education and self-exercise Sponsors: Tri-Service General Hospital Completed
- Diagnostic and Clinical Management of Non-Obstructive Myocardial Ischemia in Patients With Long Covid-19 Syndrome and New Onset Chest Painon 15 mai 2026
Conditions: Angina (Stable); INOCA (Ischemia With Non Obstructive Coronary Artery Disease); Long COVID-19 Syndrome Interventions: Diagnostic Test: Coronary functional test Sponsors: Fundacion […]
- DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injuryon 15 mai 2026
Conditions: Tinnitus Interventions: Drug: DMSO-based otic solution with betahistine, dexamethasone, and lidocaine; Drug: DMSO-based transdermal cream with levocarnitine and N-acetylcysteine […]
- Understanding the Long-term Impact of COVID-19 in Adultson 10 avril 2026
Conditions: Long COVID; Long Covid19 Sponsors: NYU Langone Health; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
- Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19on 10 avril 2026
Conditions: COVID-19 Interventions: Other: Hospitalization Sponsors: Assistance Publique - Hôpitaux de Paris; URC-CIC Paris Descartes Necker Cochin Completed
- Bright Light Therapy for Post-COVID-19 Fatigueon 10 avril 2026
Conditions: Post COVID-19 Condition Interventions: Device: Bright light therapy; Device: Dim red light therapy Sponsors: Chinese University of Hong Kong Completed
- Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseaseson 10 avril 2026
Conditions: Long COVID Symptoms Interventions: Device: enhanced external counterpulsation Sponsors: National Defense Medical Center, Taiwan Completed
- Persistent COVID-19 Registry in Navarre.on 16 mars 2026
Conditions: Long COVID Symptoms; Long COVI Sponsors: Fundacion Miguel Servet Recruiting
- A Fasting Pilot Study for Long COVIDon 16 mars 2026
Conditions: Long COVID Syndrome Interventions: Other: prolonged fasting Sponsors: Université de Sherbrooke; Centre de recherche du CHU de Sherbrooke Completed
- Effect of Daily Walnut Consumption on Memory in Subjects With Long-COVIDon 16 mars 2026
Conditions: Long-COVID; Brain Fog; Cognition; Memory Interventions: Other: whole food - walnuts Sponsors: University of California, Los Angeles Completed
- Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluationon 16 mars 2026
Conditions: Post-COVID Condition; Long COVID; Sequelae of COVID-19 Interventions: Other: Post-COVID Clinical Assessment Sponsors: Elazıg Fethi Sekin Sehir Hastanesi Recruiting
- Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome?on 16 mars 2026
Conditions: ME/CFS; Long COVID; Post- COVID-19 Syndrome; POTS - Postural Orthostatic Tachycardia Syndrome; Fibromyalgia; Overtraining Syndrome; Post-Viral Fatigue Syndrome; Mast Cell Activation […]
- Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatmentson 16 mars 2026
Conditions: Post COVID-19 Condition; Post-COVID-19 Syndrome; Post-COVID Syndrome; COVID-19; Fatigue; Fatigue Syndrome, Chronic Interventions: Device: Monoplace Hyperbaric Chamber (Class III medical […]
- Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)on 6 février 2026
Conditions: Post-Acute COVID-19 Syndrome Interventions: Drug: Keytruda Sponsors: National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting
- Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trialon 6 février 2026
Conditions: Long COVID Interventions: Procedure: Stellate Ganglion Block (Bupivacaine); Procedure: placebo saline injection Sponsors: Centre intégré universitaire de santé et de services sociaux […]
Formation continue
- 3rd Long COVID International Conference 2025on 15 mai 2026
- 3rd Canadian Symposium on Long COVID | Cross-Pillar Discussionon 15 mai 2026
This closing session brings together voices from research, clinical practice, and lived experience to reflect on the key insights and lessons shared throughout the 3rd Canadian Symposium on Long […]
- ISLC-PAIS Conference 2026 in Amsterdamon 15 mai 2026
26 – 29 August, 2026 Amsterdam (the Netherlands) Join Lionhearted ScienceUnited Against Long COVID & PAIS Post-Acute Infection Syndromes (PAIS), including Long COVID, are among the most […]
- 4th Long COVID International Conference 2026on 15 mai 2026
This conference aims to raise awareness, clarify misconceptions, promote understanding, and stimulate discussion amongst healthcare professionals, investigators, policymakers, and community […]
- International ME/CFS Conference 2026on 10 avril 2026
Under the stewardship of Prof Carmen Scheibenbogen, Director of the Division of Immunodeficiencies and Post-infectious Diseases and the Charité Fatigue Center (CFC) at Charité – […]
- 2025 Symposiumon 10 avril 2026
Emera Innovation Exchange, Signal Hill Campus, Memorial University St. John’s, Newfoundland. Background Long Covid Web and Memorial University of Newfoundland are pleased to announce the […]
- Entrez dans le labyrinthe de Lyme - Radio-Canadaon 16 mars 2026
Entrez dans le labyrinthe de Lyme Radio-Canada
- 2026_Program_LTBDI_Symposium.pdfon 6 février 2026
- Looking at the Pandemic in the Rearview Mirror: Successes, Failures and Unintended Consequences. Conference, May 2025.on 6 février 2026
Supporting the generation of high-quality evidence for public health emergencies. Fostering effective and efficient knowledge exchange for global public health emergencies. Inspiring policymakers […]
- 2026 International Forum on COVID Rehabilitation Researchon 6 février 2026
Rob Wüst is an Associate Professor at the Faculty of Behavioral and Movement Sciences at the Vrije Universiteit Amsterdam. His research group studies skeletal and cardiac muscle metabolism and […]
- 2026 Symposiumon 6 février 2026
Long Covid Web and the University of British Columbia are pleased to announce the 2026 Canadian Symposium on Long COVID. The Symposium will bring together people with lived experience of Long COVID, […]
Revue d'actualités
- Long Covid Service Extended to Cover Wider Range of Conditions - NHS Forth Valleyon 15 mai 2026
Long Covid Service Extended to Cover Wider Range of Conditions NHS Forth Valley
- Long COVID: 3 years in - The Lanceton 15 mai 2026
Long COVID: 3 years in The Lancet
- Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques - Radio-Canadaon 15 mai 2026
Une experte déplore l’arrêt du rapport provincial sur la surveillance des tiques Radio-Canada
- Designing Nutrition Studies for Long COVID and Related Infection-Associated Chronic Illness: Qualitative Insights From a Patient-Reported Evaluation of Ketogenic Metabolic Therapyon 15 mai 2026
J Patient Exp. 2026 Apr 13;13:23743735261442541. doi: 10.1177/23743735261442541. eCollection 2026.ABSTRACTBACKGROUND: Long COVID affects over 400 million people worldwide and has no FDA-approved […]
- COVID longue | Une équipe de l’IRCM est sur une nouvelle piste - La Presseon 15 mai 2026
COVID longue | Une équipe de l’IRCM est sur une nouvelle piste La Presse
- 1400 jours avec la COVID longue; les dernières découvertes pour l’espoir de guérir - Radio-Canadaon 15 mai 2026
1400 jours avec la COVID longue; les dernières découvertes pour l’espoir de guérir Radio-Canada
- La COVID longue coûtera des milliards au cours de la prochaine décennie, avertit l’OCDE - Radio-Canadaon 15 mai 2026
La COVID longue coûtera des milliards au cours de la prochaine décennie, avertit l’OCDE Radio-Canada
- Une exposition d’art dévoile les défis quotidiens du syndrome de fatigue chronique - Radio-Canadaon 15 mai 2026
Une exposition d’art dévoile les défis quotidiens du syndrome de fatigue chronique Radio-Canada
- De l'espoir pour le syndrome de fatigue chronique, une maladie multisystémique - Psychomédiaon 15 mai 2026
De l'espoir pour le syndrome de fatigue chronique, une maladie multisystémique Psychomédia
- Disperser le brouillard autour de l’encéphalomyélite myalgique - Université de Montréalon 15 mai 2026
Disperser le brouillard autour de l’encéphalomyélite myalgique Université de Montréal
- New McGill University study seeks to better understand the lingering symptoms of long COVID - CBCon 10 avril 2026
New McGill University study seeks to better understand the lingering symptoms of long COVID CBC
- Un antidépresseur pourrait traiter les symptômes de fatigue liés à la COVID longue, selon une étude - Noovo Infoon 10 avril 2026
Un antidépresseur pourrait traiter les symptômes de fatigue liés à la COVID longue, selon une étude Noovo Info
- Restructuration des soins pour les patients atteints de COVID de longue durée - Radio-Canadaon 10 avril 2026
Restructuration des soins pour les patients atteints de COVID de longue durée Radio-Canada
- “Emmurés vivants, dans l'indifférence ” : atteints d'encéphalomyélite myalgique, des patients témoignent du quotidien infernal qu'impose cette maladie - France 3 Régionson 10 avril 2026
“Emmurés vivants, dans l'indifférence ” : atteints d'encéphalomyélite myalgique, des patients témoignent du quotidien infernal qu'impose cette maladie France 3 Régions
- Sujet du livre «Clara est là» | Qu’est-ce qui se cache derrière le syndrome de fatigue chronique? - 98.5 Montréalon 10 avril 2026
Sujet du livre «Clara est là» | Qu’est-ce qui se cache derrière le syndrome de fatigue chronique? 98.5 Montréal
- Antidepressant relieves fatigue in people with long COVID, study finds - CIDRAPon 10 avril 2026
Antidepressant relieves fatigue in people with long COVID, study finds CIDRAP
- Fatigue chronique : et si la solution se trouvait dans nos intestins ? - National Geographicon 10 avril 2026
Fatigue chronique : et si la solution se trouvait dans nos intestins ? National Geographic
- Long COVID — Here’s What To Know And The Challenges Ahead - Forbeson 16 mars 2026
Long COVID — Here’s What To Know And The Challenges Ahead Forbes
- Mapping spatial and social inequities of long COVID across the United States: a retrospective cohort studyon 16 mars 2026
Lancet Reg Health Am. 2026 Feb 13;56:101401. doi: 10.1016/j.lana.2026.101401. eCollection 2026 Apr.ABSTRACTBACKGROUND: Long COVID affects a substantial portion of the U.S. population. The emergence […]
- Restructuration des soins pour les patients atteints de COVID de longue durée - Radio-Canadaon 16 mars 2026
Restructuration des soins pour les patients atteints de COVID de longue durée Radio-Canada
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


